$Stock*Shop*Charts*News*Option$

[Tuff-Stuff]

CYBX=LIVN, posted the change and links back when occurred. NO that board still has NOT been changed

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=130450487

$80.33 close on Friday NASDAQ

Still an amazing company, and a huge part of the "Special One's" life.

Company Overview

LivaNova is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. Our advanced technologies and breakthrough treatments provide meaningful solutions for the benefit of patients, healthcare professionals and healthcare systems.

At LivaNova, we understand the importance of bringing both clinical and economic value to our customers. We are a strong, market-leading medical technology and services company, offering a diverse product portfolio and global reach. LivaNova is listed on the NASDAQ stock exchange under the ticker symbol “LIVN.”

LivaNova is a market leader with a workforce of more than 4,500 employees worldwide. We are headquartered in London (UK) and maintain a presence in more than 100 countries. LivaNova operates as three business franchises:

Cardiac Surgery: We are a global leader in cardiac surgery based on many factors, including our established leadership position in heart-lung machines and recognition as the world’s #1 cardiopulmonary bypass company. Our advanced solutions have made significant contributions to open-heart surgery outcomes for many patients. Notably, we offer the only sutureless valve for aortic surgery.

Neuromodulation: As pioneers of the VNS (Vagus Nerve Stimulation) Therapy® system, we continue to advance medical device solutions for people affected by treatment-resistant epilepsy, depression and heart failure.

Cardiac Rhythm Management: Reflecting our spirit of imagination and invention, we have a long history of designing cardiac rhythm management systems, including pacemakers and defibrillators, that enhance and extend lives.

At LivaNova, we serve health and improve lives. Day by day. Life by life.

http://investor.livanova.com/phoenix.zhtml?c=254127&p=irol-IRHome

December 5

LivaNova to Acquire ImThera Medical, Inc.

Company will enter obstructive sleep apnea space, enhancing its portfolio of Neuromodulation treatments and therapies

LONDON--(BUSINESS WIRE)--Dec. 5, 2017-- LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, today announced it has entered into an agreement to acquire the remaining outstanding interests in ImThera Medical, Inc. (“ImThera”). Headquartered in San Diego, Calif., ImThera is a privately held company focused on neurostimulation for the treatment of obstructive sleep apnea (“OSA”). ImThera manufactures an implantable device that stimulates multiple tongue muscles via the hypoglossal nerve, which opens the airway while a patient is sleeping.

“The ImThera device is highly aligned with our existing Neuromodulation business, and we are extremely excited about the opportunity to optimize the technology and fold it into our universal platform. In the near term, we will focus on expanding ImThera’s current commercial presence in the European market, while advancing enrollment in a U.S. Food and Drug Administration (FDA) pivotal trial,” said Damien McDonald, LivaNova’s Chief Executive Officer. “The OSA market is large and growing, with many unmet needs. With our strong commercial capabilities and robust manufacturing, we look forward to bringing this innovative technology to the large patient population that has been unsuccessful with other treatments, allowing them to improve their quality of life.”
http://investor.livanova.com/phoenix.zhtml?c=254127&p=irol-newsArticle&ID=2321017